Paleovirology and virally derived immunity

Trends in Ecology and Evolution

Volumn 27, Issue 11, 2012, Pages 627-636

  Aswad, Amr ^a   Katzourakis, Aris ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; DATA SET; EMERGENCE; EVOLUTIONARY BIOLOGY; GENOMICS; HERITABILITY; IMMUNITY; INHIBITOR; TAXONOMY; VIRUS;

ANIMAL; EVOLUTION; GENETICS; GENOME; HORIZONTAL GENE TRANSFER; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNOLOGY; PATHOGENICITY; REVIEW; VIROLOGY; VIRUS; VIRUS INFECTION;

ANIMALS; BIOLOGICAL EVOLUTION; GENE TRANSFER, HORIZONTAL; GENOME; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; VIRUS DISEASES; VIRUSES;

EID: 84867218805     PISSN: 01695347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tree.2012.07.007     Document Type: Review

References (99)

1. Kristensen D.M., et al. New dimensions of the virus world discovered through metagenomics. Trends Microbiol. 2010, 18:11-19.
2. Feschotte C., Gilbert C. Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 2012, 13:283-296.
3. Katzourakis A., Gifford R.J. Endogenous viral elements in animal genomes. PLoS Genet. 2010, 6:e1001191.
4. Patel M.R., et al. Paleovirology: ghosts and gifts of viruses past. Curr. Opin. Virol. 2011, 1:304-309.
5. Holmes E.C. The evolution of endogenous viral elements. Cell Host Microbe 2011, 10:368-377.
6. Stoye J.P. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat. Rev. Microbiol. 2012, 10:395-406.
7. Han G.-Z., Worobey M. Endogenous lentiviral elements in the weasel family (Mustelidae). Mol. Biol. Evol. 2012, 29:2905-2908.
8. Keckesova Z., et al. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 2009, 384:7-11.
9. Malik H.S., Henikoff S. Positive selection of Iris, a retroviral envelope-derived host gene in Drosophila melanogaster. PLoS Genet. 2005, 1:e44.
10. Wang T., et al. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18613-18618.
11. Beyer U., et al. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3624-3629.
12. Cohen C.J., et al. Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 2009, 448:105-114.
13. Horie M., et al. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 2010, 463:84-87.
14. Meyerson N.R., Sawyer S.L. Two-stepping through time: mammals and viruses. Trends Microbiol. 2011, 19:286-294.
15. Emerman M., Malik H.S. Paleovirology: modern consequences of ancient viruses. PLoS Biol. 2010, 8:e1000301.
16. Best S., et al. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 1996, 382:826-829.
17. Han G.-Z., Worobey M. An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog. 2012, 8:e1002790.
18. Odaka T., et al. Inheritance of susceptibility to Friend mouse leukemia virus. Jpn. J. Exp. Med. 1962, 32:405-413.
19. Masuda M., Yoshikura H. Construction and characterization of the recombinant Moloney murine leukemia viruses bearing the mouse Fv-4 env gene. J. Virol. 1990, 64:1033-1043.
20. Taylor G.M., et al. Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus. J. Virol. 2001, 75:11244-11248.
21. Wu T., et al. Rmcf2, a xenotropic provirus in the Asian mouse species Mus castaneus, blocks infection by polytropic mouse gammaretroviruses. J. Virol. 2005, 79:9677-9684.
22. Jung Y.T., et al. Characterization of a polytropic murine leukemia virus proviral sequence associated with the virus resistance gene Rmcf of DBA/2 mice. J. Virol. 2002, 76:8218-8224.
23. Spencer T.E., et al. Receptor usage and fetal expression of ovine endogenous betaretroviruses: implications for coevolution of endogenous and exogenous retroviruses. J. Virol. 2003, 77:749-753.
24. Tikhonenko A.T., Lomovskaya O.L. Avian endogenous provirus (ev-3) env gene sequencing: implication for pathogenic retrovirus origination. Virus Genes 1990, 3:251-258.
25. McDougall A.S., et al. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J. Virol. 1994, 68:2151-2160.
26. Hartley J.W., et al. Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures. J. Virol. 1970, 5:221-225.
27. Pincus T., et al. A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J. Exp. Med. 1971, 133:1219-1233.
28. Yan Y., et al. Origin, antiviral function and evidence for positive selection of the gammaretrovirus restriction gene Fv1 in the genus Mus. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3259-3263.
29. Stoye J.P. Fv1, the mouse retrovirus resistance gene. Rev. Sci. Tech. 1998, 17:269-277.
30. Mura M., et al. Late viral interference induced by transdominant Gag of an endogenous retrovirus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11117-11122.
31. Valle R.P., Wickner R.B. Elimination of L-A double-stranded RNA virus of Saccharomyces cerevisiae by expression of gag and gag-pol from an L-A cDNA clone. J. Virol. 1993, 67:2764-2771.
32. Taylor D.J., Bruenn J. The evolution of novel fungal genes from non-retroviral RNA viruses. BMC Biol. 2009, 7:88.
33. Crittenden L.B., et al. Influence of endogenous viral (ev) gene expression and strain of exogenous avian leukosis virus (ALV) on mortality and ALV infection and shedding in chickens. Avian Dis. 1984, 28:1037-1056.
34. Silva R.F., et al. Hypervariability in the envelope genes of subgroup J avian leukosis viruses obtained from different farms in the United States. Virology 2000, 272:106-111.
35. Sacco M.A., et al. Assessing the roles of endogenous retrovirus EAV-HP in avian leukosis virus subgroup J emergence and tolerance. J. Virol. 2004, 78:10525-10535.
36. Young G.R., et al. Negative selection by an endogenous retrovirus promotes a higher-avidity CD4(+) T cell response to retroviral infection. PLoS Pathog. 2012, 8:e1002709.
37. Acha-Orbea H., MacDonald H.R. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 1995, 13:459-486.
38. Barnett A., et al. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss. J. Virol. 1999, 73:6634-6645.
39. Bhadra S., et al. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis. J. Virol. 2009, 83:484-488.
40. Miller K., et al. Identification of multiple gypsy LTR-retrotransposon lineages in vertebrate genomes. J. Mol. Evol. 1999, 49:358-366.
41. Kapoor A., et al. Discovery and characterization of mammalian endogenous parvoviruses. J. Virol. 2010, 84:12628-12635.
42. Cui J., Holmes E.C. Endogenous lentiviruses in the ferret genome. J. Virol. 2012, 86:3383-3385.
43. van der Kuyl A.C. Characterization of a full-length endogenous beta-retrovirus, EqERV-beta1, in the genome of the horse (Equus caballus). Viruses 2011, 3:620-628.
44. Taylor D.J., et al. Evolutionary maintenance of filovirus-like genes in bat genomes. BMC Evol. Biol. 2011, 11:336.
45. Sawyer S.L., et al. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2832-2837.
46. OhAinle M., et al. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 2008, 4:249-259.
47. Ikeda H., et al. Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance. J. Virol. 1985, 55:768-777.
48. Trowsdale J., Parham P. Mini-review: defense strategies and immunity-related genes. Eur. J. Immunol. 2004, 34:7-17.
49. Gilman R.T., et al. Coevolution in multidimensional trait space favours escape from parasites and pathogens. Nature 2012, 483:328-330.
50. Bhadra S., et al. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog. 2006, 2:e128.
51. Lepperdinger G., et al. Hyal2: less active, but more versatile?. Matrix Biol. 2001, 20:509-514.
52. Jadin L., et al. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?. FASEB J. 2008, 22:4316-4436.
53. Folimonova S.Y. Superinfection exclusion is an active virus-controlled function that requires a specific viral protein. J. Virol. 2012, 86:5554-5561.
54. Ehrengruber M.U., Goldin A.L. Semliki Forest virus vectors with mutations in the nonstructural protein 2 gene permit extended superinfection of neuronal and non-neuronal cells. J. Neurovirol. 2007, 13:353-363.
55. Claus C., et al. Rubella virus-induced superinfection exclusion studied in cells with persisting replicons. J. Gen. Virol. 2007, 88:2769-2773.
56. Walters K.-A., et al. Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen. J. Virol. 2004, 78:7925-7937.
57. Tscherne D.M., et al. Superinfection exclusion in cells infected with hepatitis C virus. J. Virol. 2007, 81:3693-3703.
58. Geib T., et al. Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J. Virol. 2003, 77:4283-4290.
59. Horie M., Tomonaga K. Non-retroviral fossils in vertebrate genomes. Viruses 2011, 3:1836-1848.
60. Innan H., Kondrashov F. The evolution of gene duplications: classifying and distinguishing between models. Nat. Rev. Genet. 2010, 11:97-108.
61. Marco A., Marín I. CGIN1: a retroviral contribution to mammalian genomes. Mol. Biol. Evol. 2009, 26:2167-2170.
62. Sanville B., et al. Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove. PLoS Pathog. 2010, 6:e1000974.
63. Roossinck M.J. The good viruses: viral mutualistic symbioses. Nat. Rev. Microbiol. 2011, 9:99-108.
64. Filée J., et al. Phylogenetic evidence for extensive lateral acquisition of cellular genes by nucleocytoplasmic large DNA viruses. BMC Evol. Biol. 2008, 8:320.
65. Jayawardane G., et al. A captured viral interleukin 10 gene with cellular exon structure. Gen. Virol. 2008, 89:2447-2455.
66. Slobedman B., et al. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J. Virol. 2009, 83:9618-9629.
67. Frost L.S., et al. Mobile genetic elements: the agents of open source evolution. Nat. Rev. Microbiol. 2005, 3:722-732.
68. van der Oost J., et al. CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem. Sci. 2009, 34:401-407.
69. Fabozzi G., et al. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J. Virol. 2011, 85:2512-2523.
70. Fort P., et al. Fossil rhabdoviral sequences integrated into arthropod genomes: ontogeny, evolution, and potential functionality. Mol. Biol. Evol. 2011, 29:381-390.
71. Bock R. The give-and-take of DNA: horizontal gene transfer in plants. Trends Plant Sci. 2010, 15:11-22.
72. Koonin E.V. Taming of the shrewd: novel eukaryotic genes from RNA viruses. BMC Biol. 2010, 8:2.
73. Tarlinton R.E., et al. Retroviral invasion of the koala genome. Nature 2006, 442:79-81.
74. Maori E., et al. Reciprocal sequence exchange between non-retro viruses and hosts leading to the appearance of new host phenotypes. Virology 2007, 362:342-349.
75. Lusso P. HIV and the chemokine system: 10 years later. EMBO J. 2006, 25:447-456.
76. Balanovsky O., et al. Is spatial distribution of the HIV-1-resistant CCR5Delta32 allele formed by ecological factors?. J. Physiol. Anthropol. Appl. Hum. Sci. 2005, 24:375-382.
77. Faure E., Royer-Carenzi M. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?. Infect. Genet. Evol. 2008, 8:864-874.
78. Dunlap K.A., et al. Endogenous retroviruses regulate periimplantation placental growth and differentiation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14390-14395.
79. Llorens C., et al. The Gypsy Database (GyDB) of mobile genetic elements: release 2.0. Nucleic Acids Res. 2011, 39:D70-D74.
80. Bénit L., et al. Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J. Virol. 2001, 75:11709-11719.
81. Cornelis G., et al. Ancestral capture of syncytin-Car1, a fusogenic endogenous retroviral envelope gene involved in placentation and conserved in Carnivora. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E432-E441.
82. Campillos M., et al. Computational characterization of multiple Gag-like human proteins. Trends Genet. 2006, 22:585-589.
83. Malik H.S. Retroviruses push the envelope for mammalian placentation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2184-2185.
84. Katzourakis A., et al. Macroevolution of complex retroviruses. Science 2009, 325:1512.
85. Gould S., Vrba E. Exaptation: a missing term in the science of form. Paleobiology 1982, 8:4-15.
86. Dupressoir A., et al. Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:725-730.
87. Mi S., et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000, 403:785-789.
88. Gilbert C., Feschotte C. Genomic fossils calibrate the long-term evolution of hepadnaviruses. PLoS Biol. 2010, 8:12.
89. Lefeuvre P., et al. Evolutionary time-scale of the begomoviruses: evidence from integrated sequences in the Nicotiana genome. PLoS ONE 2011, 6:e19193.
90. Hatziioannou T., Bieniasz P.D. Antiretroviral restriction factors. Curr. Opin. Virol. 2011, 1:526-532.
91. Nisole S., et al. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
92. Blanc V., Davidson N.O. APOBEC-1-mediated RNA editing. Wiley Interdisciplinary Rev. Syst. Biol. Med. 2010, 2:594-602.
93. Hultquist J.F., et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 2011, 85:11220-11234.
94. Mehle A., et al. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 2004, 279:7792-7798.
95. Laguette N., et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
96. Rey-Cuillé M.A., et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 1998, 72:3872-3886.
97. Müller V., De Boer R.J. The integration hypothesis: an evolutionary pathway to benign SIV infection. PLoS Pathog. 2006, 2:e15.
98. Borghans J.A.M., et al. Limited role for the thymus in SIV pathogenesis. Eur. J. Immunol. 2005, 35:42-45.
99. Lynch C., Tristem M. A co-opted gypsy-type LTR-retrotransposon is conserved in the genomes of humans, sheep, mice, and rats. Curr. Biol. 2003, 13:1518-1523.